Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NeoMTA 2 vs White MTA in Revascularization of Immature Teeth
NCT06637761Phase 2Not yet recruiting
- Sponsor
- Cairo University
- Start
- Oct 2024
- Primary completion
- Oct 2025
- Modality
- Implantable Devices
01
Overview
Phase 2, randomised trial of NeoMTA 2 in pulp necrosis (2 arms), sponsored by Cairo University. Primary endpoint: Discoloration at 1 year. Planned start Oct 2024; status: not yet recruiting.
02
Drugs
NeoMTA 2
03
Conditions
pulp necrosis
Beyond the preview
Go deeper on NCT06637761.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06637761.